2001•The Pharmacogenomics JournalRequires access

The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels

Reinhold Kerb, A.S. Aynacioglu, Jürgen Brockmöller, Robert Schlagenhaufer, Steffen Bauer, Thomas Szekeres, Ahmad Hamwi, Thomas Szekeres, Christian Baumgärtner, Hatice Z. Ongen, Pinar Güzelbey, Ivar Roots, Ulrich Brinkmann

Open publisher page 133 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 133 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Phenytoin, CYP2C9, CYP2C19, Genotype, Pharmacology, Anticonvulsant, Pharmacokinetics, Genotyping

Back to paper search Browse research topics Original source

The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels — Research Paper | ScholarLens